SMTL ID : 5k7k.1

Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7: Discovery of Clinical Candidate PF-05089771

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 28 residues within 4Å: Chain A: R.80, I.95, V.96, W.103, R.107, I.161, A.280, G.281, T.284, T.285, T.288, Q.339, L.344, L.345, S.348, L.349, H.351, L.374, P.410, F.411, S.412, R.416, C.418, V.419, G.420, L.423, A.424 Ligands: 6RJ.2 18 PLIP interactions: 18 interactions with chain A, Hydrophobic interactions: A:I.95, A:I.161, A:A.280, A:L.344, A:L.345, A:L.374, A:F.411, A:F.411, A:V.419, A:L.423 Hydrogen bonds: A:V.96, A:S.348, A:S.412 Salt bridges: A:R.80, A:R.80, A:H.351, A:R.416 Metal complexes: A:C.418

1 x 6RJ: 4-[4-chloranyl-2-(1~{H}-pyrazol-4-yl)phenoxy]-3-cyano-~{N}-(1,3-thiazol-2-yl)benzenesulfonamide(Non-covalent)

6RJ.2: 18 residues within 4Å: Chain A: F.83, R.91, F.97, L.184, N.187, I.188, L.191, M.223, V.275, G.279, A.280, E.283, T.284, L.345, S.348, L.349, F.459 Ligands: HEM.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.83, A:F.97, A:L.191, A:A.280, A:L.349 Hydrogen bonds: A:R.91, A:N.187, A:T.284

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Swain, N.A. et al., Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7. J. Med. Chem. (2017)

Release Date

2017-06-07

Peptides

Cytochrome P450 2C9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cytochrome P450 2C9

Related Entries With Identical Sequence